LINC02288 promotes chondrocyte apoptosis and inflammation through miR-374a-3p targeting RTN3.

Our findings indicate that LINC02288 contributes to OA progression by targeting the miR-374a-3p/RTN3 axis, which might provide a promising molecular therapy strategy for OA.